First in Patient Study for PF-06840003 in Malignant Gliomas

NCT02764151 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
17
Enrollment
INDUSTRY
Sponsor class

Stopped Sponsor decided to prematurely terminate the study and not to pursue marketing approval for the indication of malignant glioma.

Conditions

Interventions

Sponsor

Pfizer